图书简介

<p>1. Introduction.- 2. Evidence based medicine: levels of evidence and evaluation systems.- 3. Decision analytic techniques and other decision processes.- 4. Decision making - the surgeon?s perspective.- 5. Decision making - the patient?s perspective.- 6. <b>EBUS vs mediastinoscopy for initial pathologic mediastinal staging in NSCLC</b>.- 7. Is preoperative smoking cessation for lung resection patients effective in reducing surgical morbidity.- 8. <b>Is low tech as good as high tech exercise testing in assessing healthy candidates for lung resection</b>.- 9. <b>Does assessment of frailty and sarcopenia in lung resection candidates affect oatient selection</b>.- 10. <b>Can frailty and sarcopenia be mitigated in lung resection candidates</b>.- 11. Is antibiotic prophylaxis necessary for major lung resection.- 12. <b>Uniportal vs multiportal VATS lobectomy</b>.- 13. Robotic vs VATS for major lung resection.- 14. <b>Does intrapleural therapy for persistent postoperative air leak reduce air leak duration</b>.- 15. <b>Segmentectomy vs lobectomy in patients with good pulmonary function</b>.- 16. Is resection of persistent N2 disease after induction therapy effective.- 17. <b>N2 disease discovered at the time of lung resection - resect or abort?</b>.- 18. <b>Is lung resection safe after immunotherapy</b>.- 19. <b>Is an enhanced recovery programs for lobectomy patients effective in improving surgical outcomes</b>.- 20. Resection vs SBRT for stage I NSCLC in patients with good pulmonary function.- 21. Do endobronchial valves assist in resolution of postoperative persistent air leak.- 22. Is long-term surveillance effective after resection of stage I NSCLC.- 23. Does ECMO for lung failure in ICU patients improve survival.- 24. <b>Does resection of oligometastatic disease in lung cancer patients improve survival</b>.- 25. Is pulmonary metastasectomy effective in prolonging survival.- 26. <b>Resection vs endoscopic therapy for T1bN0 esophageal adenocarcinoma</b>.- 27. <b>Does induction therapy for T2N0 esophageal adenocarcinoma improve survival</b>.- 28. <b>Do enhanced recovery programs for esophagectomy patients improve outcomes</b>.- 29. <b>Does jejunostomy after esophagectomy improve outcomes</b>.- 30. Surgery vs definitive chemoradiotherapy for regionally advanced esophageal squamous cell cancer.- 31. <b>Open vs robotic resection for esophageal adenocarcinoma</b>.- 32. Two-field vs three-field lymphadenectomy for esophageal adenocarcinoma.- 33. <b>Is resection of more nodes better for treating esophageal cancer</b>.- 34. Salvage esophagectomy for persistent disease after definitive chemoradiotherapy.- 35. Early postoperative feeding after esophagectomy.- 36. Stent vs primary repair for esophageal perforation.- 37. <b>Sump therapy vs stenting

Trade Policy 买家须知